Renewable, recombinant antibodies to histone post-translational modifications

Variability in the quality of antibodies to histone post-translational modifications (PTMs) presents widely recognized hindrance in epigenetics research. Here, by using antibody engineering technologies we produced recombinant antibodies directed to the trimethylated lysine residues of histone H3 wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Takamitsu, Taft, Joseph M., Swist, Kalina M., Luo, Hao, Witt, Heather, Slattery, Matthew, Koide, Akiko, Ruthenburg, Alexander J., Krajewski, Krzysztof, Strahl, Brian D., White, Kevin P., Farnham, Peggy J., Zhao, Yingming, Koide, Shohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828030/
https://www.ncbi.nlm.nih.gov/pubmed/23955773
http://dx.doi.org/10.1038/nmeth.2605
Descripción
Sumario:Variability in the quality of antibodies to histone post-translational modifications (PTMs) presents widely recognized hindrance in epigenetics research. Here, by using antibody engineering technologies we produced recombinant antibodies directed to the trimethylated lysine residues of histone H3 with high specificity and affinity and no lot-to-lot variation. These recombinant antibodies performed well in common epigenetics applications, and their high specificity enabled us to identify positive and negative correlations among histone PTMs.

Ejemplares similares